Harmony Biosciences Holdings (HRMY) Gross Margin (2020 - 2025)
Historic Gross Margin for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to 75.09%.
- Harmony Biosciences Holdings' Gross Margin fell 19200.0% to 75.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 77.7%, marking a year-over-year decrease of 9600.0%. This contributed to the annual value of 78.06% for FY2024, which is 11100.0% down from last year.
- Per Harmony Biosciences Holdings' latest filing, its Gross Margin stood at 75.09% for Q3 2025, which was down 19200.0% from 80.97% recorded in Q2 2025.
- Harmony Biosciences Holdings' Gross Margin's 5-year high stood at 82.81% during Q2 2021, with a 5-year trough of 72.97% in Q4 2024.
- For the 5-year period, Harmony Biosciences Holdings' Gross Margin averaged around 80.15%, with its median value being 81.37% (2023).
- As far as peak fluctuations go, Harmony Biosciences Holdings' Gross Margin crashed by -46700bps in 2023, and later soared by 4600bps in 2025.
- Quarter analysis of 5 years shows Harmony Biosciences Holdings' Gross Margin stood at 80.47% in 2021, then dropped by -2bps to 79.05% in 2022, then fell by -6bps to 74.38% in 2023, then fell by -2bps to 72.97% in 2024, then increased by 3bps to 75.09% in 2025.
- Its Gross Margin was 75.09% in Q3 2025, compared to 80.97% in Q2 2025 and 82.68% in Q1 2025.